Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Characterization of glycidol-hemoglobin adducts as biomarkers of exposure and in vivo dose
Stockholms universitet, Naturvetenskapliga fakulteten, Institutionen för material- och miljökemi (MMK).
2014 (Engelska)Ingår i: Toxicology and Applied Pharmacology, ISSN 0041-008X, E-ISSN 1096-0333, Vol. 275, nr 3, s. 213-220Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Hemoglobin adducts have been used as biomarkers of exposure to reactive chemicals. Glycidol, an animal carcinogen, has been reported to form N-(2,3-dihydroxy-propyl)valine adducts to hemoglobin (diHOPrVal). To support the use of these adducts as markers of glycidol exposure, we investigated the kinetics of diHOPrVal formation and its elimination in vitro and in vivo. Five groups of rats were orally administered a single dose of glycidol ranging from 0 to 75 mg/kg bw, and diHOPrVal levels were measured 24 h after administration. A dose-dependent increase in diHOPrVal levels was observed with high linearity (R-2 = 0.943). Blood sampling at different time points (1, 10, 20, or 40 days) from four groups administered glycidol at 12 mg/kg bw suggested a linear decrease in diHOPrVal levels compatible with the normal turnover of rat erythrocytes (life span, 61 days), with the calculated first-order elimination rate constant (k(el)) indicating that the diHOPrVal adduct was chemically stable. Then, we measured the second-order rate constant (k(val)) for the reaction of glycidol with N-terminal valine in rat and human hemoglobin in in vitro experiments with whole blood. The k(val) was 6.7 (+/-) 1.1 and 5.6 +/- 1.3 (pmol/g globin per mu Mh) in rat and human blood, respectively, indicating no species differences. In vivo doses estimated from k(val) and diHOPrVal levels were in agreement with the area under the (concentration-time) curve values determined in our earlier toxicokinetic study in rats. Our results indicate that diHOPrVal is a useful biomarker for quantification of glycidol exposure and for risk assessment.

Ort, förlag, år, upplaga, sidor
2014. Vol. 275, nr 3, s. 213-220
Nyckelord [en]
Glycidol, Hemoglobin adducts, Toxicokinetics, In vivo dose, Exposure assessment
Nationell ämneskategori
Kemi
Identifikatorer
URN: urn:nbn:se:su:diva-102959DOI: 10.1016/j.taap.2014.01.010ISI: 000333320700003OAI: oai:DiVA.org:su-102959DiVA, id: diva2:714852
Anmärkning

AuthorCount:4;

Tillgänglig från: 2014-04-29 Skapad: 2014-04-25 Senast uppdaterad: 2017-12-05Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltext

Sök vidare i DiVA

Av författaren/redaktören
Törnqvist, Margareta
Av organisationen
Institutionen för material- och miljökemi (MMK)
I samma tidskrift
Toxicology and Applied Pharmacology
Kemi

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetricpoäng

doi
urn-nbn
Totalt: 32 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf